Brazil To Break Patent On Abbott Drug In Ten Days

Law360, New York (July 1, 2005, 12:00 AM EDT) -- Brazil has informed Abbott Laboratories that it will break the company's patent on the antiretroviral drug Kaletra in the next few days unless the U.S. drug maker offers a steep price break on the HIV/AIDS drug.

Brazilian Health Minister Humberto Costa said the government would break the patent within 10 days unless the company lowers the price of the drug 42% to $1.17 per pill, according to the Financial Rimes.

If the patent is broken, generic drug manufacturers could begin producing versions of the drug, which...
To view the full article, register now.